Pemetrexed-induced organizing pneumonia in the treatment of lung adenocarcinoma

Rev Port Pneumol (2006). 2017 Nov-Dec;23(6):370-371. doi: 10.1016/j.rppnen.2017.09.003. Epub 2017 Nov 4.

Authors

N China-Pereira¹, S Campainha², A Furtado³, S Conde², A Barroso²

Affiliations

¹ Thoracic Tumors Unit, Pulmonology Department, Centro Hospitalar de Vila Nova de Gaia e Espinho, Vila Nova de Gaia, Portugal. Electronic address: nunofilipechina@msn.com.
² Thoracic Tumors Unit, Pulmonology Department, Centro Hospitalar de Vila Nova de Gaia e Espinho, Vila Nova de Gaia, Portugal.
³ Pathology Department, Centro Hospitalar de Vila Nova de Gaia e Espinho, Vila Nova de Gaia, Portugal.

PMID: 29108927
DOI: 10.1016/j.rppnen.2017.09.003

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma of Lung / drug therapy
Humans
Lung Neoplasms / drug therapy
Male
Middle Aged
Pemetrexed / adverse effects*
Pemetrexed / therapeutic use
Pneumonia / chemically induced*
Pneumonia / pathology

Substances

Pemetrexed